ABCSG https://www.abcsg.org/en/ Austrian Breast & Colorectal Cancer Study Group Wed, 02 Sep 2026 11:15:26 +0000 en-US hourly 1 ABCSG 66 / ADAPTela: First Site Activated and First Patient Enrolled https://www.abcsg.org/en/abcsg-66-adaptela-first-site-activated-and-first-patient-enrolled/ Wed, 02 Sep 2026 11:10:19 +0000 https://www.abcsg.org/?p=42160 ABCSG 66 / ADAPTela Study design

The ABCSG is pleased to announce that the first Austrian site has been activated for the ABCSG 66 / ADAPTela trial, where the first patient has also been enrolled. The Department of Gynecology at the Medical University of Innsbruck, under the leadership of Dr. Daniel Egle, was activated for patient enrollment on August 21, 2026. […]

Source

]]> Enrollment target reached for the ABCSG 62 / CAMBRIA-2 trial https://www.abcsg.org/en/enrollment-target-reached-for-the-abcsg-62-cambria-2-trial/ Tue, 11 Aug 2026 13:33:22 +0000 https://www.abcsg.org/?p=42006 ABCSG 62

The international phase III ABCSG 62 / CAMBRIA-2 trial has reached an important milestone: The enrollment target of 5,500 patients was achieved as planned in June 2026. By the official end of recruitment on July 1, 2026, a total of 5,511 patients has been enrolled in the trial. ABCSG 62 / CAMBRIA-2 is an international, […]

Source

]]> Enrollment target reached for the ABCSG 55N / AMBHER study https://www.abcsg.org/en/enrollment-target-reached-for-the-abcsg-55n-ambher-study/ Mon, 10 Aug 2026 11:59:03 +0000 https://www.abcsg.org/?p=41979 ABCSG 55N /AMBHER

The non-interventional ABCSG 55N / AMBHER study has reached an important milestone: The enrollment target of 500 patients was achieved in July 2026. Following the last patient inclusion on August 3, 2026, the study population comprises a total of 501 patients. ABCSG 55N / AMBHER is a non-interventional, single-arm, multicenter study with an ambispective design, […]

Source

]]> International Webinar Reshaping HER2-Positive Breast Cancer – ADCs Across the Disease Continuum https://www.abcsg.org/en/webinar-adcs-2026/ Wed, 15 Jul 2026 12:19:17 +0000 https://www.abcsg.org/webinar-adcs-2026/ Reshaping HER2-Positive Breast Cancer - ADCs Across the Disease Continuum

We invite you to join our international webinar exploring the evolving role of antibody–drug conjugates (ADCs) across the disease continuum in HER2-positive breast cancer. Moderated by ABCSG President Michael Gnant, this webinar will focus on current treatment strategies and emerging data shaping clinical decision-making in both early and metastatic settings. The event will feature internationally […]

Source

]]> International Webinar Pathways and Payloads – Combinations and Sequencing in the Treatment of Metastatic Breast Cancer https://www.abcsg.org/en/webinar-mbc-2026/ Wed, 15 Jul 2026 12:06:17 +0000 https://www.abcsg.org/webinar-mbc-2026/ Pathways and Payloads – Combinations and Sequencing in the Treatment of Metastatic Breast Cancer

We invite you to join our international webinar exploring current treatment strategies and emerging concepts in metastatic breast cancer. Moderated by ABCSG President Michael Gnant, this webinar will focus on optimizing combinations and sequencing approaches across different breast cancer subtypes and treatment settings. The event will feature internationally renowned experts Hope Rugo and Marija Balic, […]

Source

]]> Enrollment completed ahead of schedule for the ABCSG 63 / ERIKA trial https://www.abcsg.org/en/rekrutierung-der-abcsg-63-erika-studie-erfolgreich-abgeschlossen/ Mon, 13 Jul 2026 12:01:07 +0000 https://www.abcsg.org/rekrutierung-der-abcsg-63-erika-studie-erfolgreich-abgeschlossen/ ABCSG 63 / ERIKA Study Details

Recruitment for the phase II ABCSG 63 / ERIKA trial has been successfully completed. With the randomization of the 120th patient, the study reached its enrollment target two months ahead of schedule. Conducted in cooperation with the West German Study Group (WSG), ABCSG 63 / ERIKA is an open-label, two-arm, randomized phase II trial evaluating […]

Source

]]> SOLTI Young European Workshop brings together young breast cancer specialists from across Europe https://www.abcsg.org/en/solti-young-european-workshop-bringt-junge-brustkrebsexpertinnen-aus-ganz-europa-zusammen/ Tue, 30 Jun 2026 10:01:47 +0000 https://www.abcsg.org/solti-young-european-workshop-bringt-junge-brustkrebsexpertinnen-aus-ganz-europa-zusammen/ Source

]]> ABCSG Annual Report 2025 now available online! https://www.abcsg.org/en/abcsg-annual-report-2025-now-available-online/ Mon, 18 May 2026 06:38:28 +0000 https://www.abcsg.org/?p=41459 ABCSG Jahresbericht 2025

We are pleased to share the ABCSG Annual Report 2025. It provides an overview of an exceptionally successful and highly productive year for the ABCSG. With 30 publications in internationally renowned peer-reviewed journals, 2025 marked the most impactful publication year in ABCSG history. We were also able to initiate several new innovative clinical trials and […]

Source

]]> Editorial by Professor Michael Gnant published in Cancer Biology & Medicine https://www.abcsg.org/en/editorial-von-prof-michael-gnant-in-cancer-biology-medicine-veroeffentlicht/ Wed, 15 Apr 2026 09:48:02 +0000 https://www.abcsg.org/editorial-von-prof-michael-gnant-in-cancer-biology-medicine-veroeffentlicht/ Editorial by Professor Michael Gnant published in Cancer Biology & Medicine

We are pleased to share a recent editorial by ABCSG President Professor Michael Gnant, who was invited to present his assessments on the evolving landscape of breast cancer care in Cancer Biology & Medicine. Under the title “Balancing global standards and regional nuances in breast cancer care: the role of guidelines, clinical research, precision medicine, […]

Source

]]> International Profile: CancerWorld Honors Prof. Michael Gnant https://www.abcsg.org/en/internationales-portraet-cancerworld-wuerdigt-prof-michael-gnant/ Tue, 10 Mar 2026 14:13:48 +0000 https://www.abcsg.org/internationales-portraet-cancerworld-wuerdigt-prof-michael-gnant/ CancerWorld würdigt Prof. Michael Gnant

CancerWorld, published by OncoDaily, features ABCSG-president Michael Gnant in its latest issue, highlighting his influential contribution to modern breast cancer research and treatment. The article portrays a physician-scientist who has repeatedly challenged established routines and encouraged critical thinking in clinical practice. Special attention is also given to the development of ABCSG, which has evolved from […]

Source

]]> Joyful Festive Season https://www.abcsg.org/en/joyful-festive-season-2/ Tue, 23 Dec 2025 04:00:06 +0000 https://www.abcsg.org/?p=40766 Joyful Festive Season 2025

The ABCSG wishes you and your loved ones a peaceful festive season and a healthy, successful New Year. May the coming year bring confidence, positive encounters, and continued progress — both personally and professionally. Thank you for your trust, your engagement, and the valuable collaboration throughout the year.

Source

]]> 20 years at the helm of ABCSG: https://www.abcsg.org/en/20-years-at-the-helm-of-abcsg/ Sat, 15 Nov 2025 16:59:41 +0000 https://www.abcsg.org/?p=40304 20 Jahre an der Spitze der ABCSG

At this year’s ABCSG Annual Meeting, Professor Michael Gnant was honored for his 20 years of pioneering work as President of the ABCSG. The tribute took place in the presence of numerous colleagues who emphasized his continuous dedication and his significant contribution to advancing clinical cancer research in Austria. A special highlight of the evening […]

Source

]]> ABCSG 67N / CAROLEEN study: First Patient Enrolled https://www.abcsg.org/en/abcsg-67n-caroleen-study-first-patient-enrolled/ Thu, 30 Oct 2025 14:23:39 +0000 https://www.abcsg.org/?p=40181 ABCSG 67N / CAROLEEN

The ABCSG is pleased to announce that the first patient from Austria has been enrolled in the ABCSG 67N / CAROLEEN at Sanatorium Hera under the leadership of PI Yelena Devyatko. We warmly congratulate PI Yelena Devyatko and the dedicated team in Sanatorium Hera on this important first milestone. ABCSG 67N / CAROLEEN is a […]

Source

]]> ABCSG 65 / DEFINITIVE: First patient randomized https://www.abcsg.org/en/abcsg-65-definitive-first-patient-randomized/ Thu, 09 Oct 2025 09:41:58 +0000 https://www.abcsg.org/?p=39865 Study Design: ABCSG 65 The ABCSG is proud to report that the first Austrian patient has been randomized in the ABCSG 65 / DEFINITIVE trial at LKH Hochsteiermark, site Leoben, under the lead of PI Dr. Thamer Sliwa. Congratulations to Dr. Sliwa and his dedicated team in Leoben on achieving this important milestone.

The ABCSG is proud to report that the first Austrian patient has been randomized in the ABCSG 65 / DEFINITIVE trial at LKH Hochsteiermark, site Leoben, under the lead of PI Dr. Thamer Sliwa. Congratulations to Dr. Sliwa and his dedicated team in Leoben on achieving this important milestone. ABCSG 65 / DEFINITIVE (Diagnostic HER2DX-guided […]

Source

]]> ABCSG 61 / TEODOR: First Patient Registered in the Run-in Phase https://www.abcsg.org/en/abcsg-61-teodor-first-patient-registered-in-the-run-in-phase/ Thu, 14 Aug 2025 09:23:35 +0000 https://www.abcsg.org/?p=39193 ABCSG 61 Studiendesign

The ABCSG is pleased to announce another important milestone in the national phase II study ABCSG 61 / TEODOR (Neoadjuvant TrEatment Optimization driven by ctDNA and endOcrine Responsiveness). Under the coordination of Dr. Daniel Egle, the first patient was registered in the run-in phase at the Breast Health Center of the Department of Obstetrics and […]

Source

]]> ABCSG 61 / TEODOR: First center opened for patient enrollment https://www.abcsg.org/en/abcsg-61-teodor-first-center-opened-for-patient-enrollment/ Wed, 30 Jul 2025 03:00:00 +0000 https://www.abcsg.org/?p=39018 ABCSG 61 / TEODOR

The new ABCSG study ABCSG 61 / TEODOR (Neoadjuvant TrEatment Optimization driven by ctDNA and endOcrine Responsiveness) has launched with the activation of its first site – the Center for Breast Health in the Department of Gynecology at the Medical University of Vienna, headed by Prof. Christian Singer. TEODOR is dedicated to optimizing neoadjuvant treatment […]

Source

]]> CDK4/6 Inhibition in Early and Advanced Breast Cancer 2025 https://www.abcsg.org/en/cdk4-6-webinar-2025/ Sat, 28 Jun 2025 04:00:56 +0000 https://www.abcsg.org/cdk4-6-webinar-2025/ CDK4/6 Inhibition in Early and Advanced Breast Cancer 2025

We invite you to join the upcoming ABCSG webinar dedicated to the evolving role of CDK4/6 inhibitors in the treatment of hormone receptor-positive (HR+) breast cancer. This year’s session will explore both metastatic and early-stage settings, with a focus on recent trial results, clinical controversies, and practical decision-making. The event will open with a dynamic […]

Source

]]> ABCSG Featured in BIG Annual Report 2024 https://www.abcsg.org/en/abcsg-im-big-jahresbericht-2024-vertreten/ Sat, 28 Jun 2025 03:55:58 +0000 https://www.abcsg.org/abcsg-im-big-jahresbericht-2024-vertreten/ BIG-Jahresbericht

The ABCSG is once again featured in the Breast International Group’s (BIG) Annual Report, which highlights the breadth of our activities and achievements throughout 2024. The article reflects on our scientific progress amid global challenges, ABCSG’s international visibility through publications and congress presentations, operational advancements in international clinical research, and our strong commitment to education […]

Source

]]> Congratulations to Dominik Hlauschek on His First Full Publication in ESMO Open! https://www.abcsg.org/en/wir-gratulieren-unserem-statistiker-dominik-hlauschek-zu-seiner-ersten-wissenschaftlichen-vollpublikation-in-esmo-open/ Fri, 13 Jun 2025 03:50:51 +0000 https://www.abcsg.org/wir-gratulieren-unserem-statistiker-dominik-hlauschek-zu-seiner-ersten-wissenschaftlichen-vollpublikation-in-esmo-open/ The impact of analysis methodology details on invasive breast cancer-free survival in randomized clinical trials

A proud moment for the ABCSG statistics team: our colleague Dominik Hlauschek has just published his first full paper in ESMO Open — a key step in his scientific career. Congratulations – and many thanks to Christian Fesl for his leadership and to the whole statistics team for their support! This paper critically examines the […]

Source

]]> Editorial by ABCSG President Prof. Gnant in the British Journal of Surgery on the future of surgical research https://www.abcsg.org/en/editorial-von-abcsg-praesident-prof-gnant-im-british-journal-of-surgery-zur-zukunft-der-chirurgischen-forschung/ Wed, 04 Jun 2025 13:39:04 +0000 https://www.abcsg.org/editorial-von-abcsg-praesident-prof-gnant-im-british-journal-of-surgery-zur-zukunft-der-chirurgischen-forschung/ British Journal of Surgery

ABCSG President Prof. Michael Gnant has published an editorial in the British Journal of Surgery “The future of surgical research” Oxford University Press, Volume 112, Issue 6, 03. Juni 2025 https://doi.org/10.1093/bjs/znaf095 In this editorial, he reflects on the pressures currently facing academic surgery – ranging from limited resources to the challenge of placing greater value […]

Source

]]>